4.6 Article

Clinical outcome in patients with peripheral artery disease.: Results from a prospective registry (FRENA)

Journal

EUROPEAN JOURNAL OF INTERNAL MEDICINE
Volume 19, Issue 3, Pages 192-197

Publisher

ELSEVIER
DOI: 10.1016/j.ejim.2007.09.003

Keywords

outcome; peripheral arterial disease; secondary prevention

Ask authors/readers for more resources

Background: The risk of future cardiovascular events in patients with peripheral artery disease (PAD) is often underestimated. Patients and methods: FRENA is an ongoing, observational registry of consecutive outpatients with symptomatic PAD, coronary artery disease (CAD) or cerebrovascular disease (CVD). We compared the incidence of major cardiovascular events (i.e., myocardial infarction, ischemic stroke, critical limb ischemia, or cardiovascular death) during a 12-month follow-up period in a series of consecutive outpatients with PAD, CAD or CVD. Results: As of December 2006, 1265 patients had been enrolled in FRENA who completed the 12-month follow-up. Of these, 417 patients (33%) had PAD, 474 (37%) had CAD, 374 (30%) had CVD. Patients with PAD had an increased incidence of major cardiovascular events per 100 patient-years: 17 (95% CI: 13-22) vs. 7.9 (5.5-11) in those with CAD, or 8.9 (6.1-13) in those with CVD. Compared to patients with CAD or CVD those with PAD had a similar incidence of myocardial infarction or stroke, but a higher incidence of critical limb ischemia, limb amputation and death. This incidence increased with the severity of the symptoms: 8.7 (95% CI: 5.3-13) in patients in Fontaine stage IIa; 25 (95% CI: 16-38) in stage IIb; 26 (95% CI: 13-47) in stage III; 42 (95% CI: 24-67) in stage IV. Conclusions: Our data confirm a higher incidence of major cardiovascular events for patients with PAD, as well as a correlation of these events with the severity of PAD. (C) 2007 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Medicine, General & Internal

Effect of a repeated educational intervention versus an initial intervention on blood pressure control in hypertensive patients

Dolors Estrada, Rosa Ma Soriano, Ana Isabel Jordan, Carolina Fernandez, Miguel Camafort, Cristina Sierra

Summary: This study evaluated the effectiveness of a continuous therapeutic education compared to an initial intervention in hypertensive patients. The results showed that the continuous intervention group had higher scores in knowledge about hypertension and improvements in blood pressure, weight, body mass index, and abdominal girth figures.

MEDICINA CLINICA (2022)

Review Medicine, General & Internal

Is there sufficient evidence to justify changes in dietary habits in heart failure patients? A systematic review

Alejandra Garcia-Garcia, Luis A. Alvarez-Sala-Walther, Hae-Young Lee, Cristina Sierra, Domingo Pascual-Figal, Miguel Camafort

Summary: The incidence and prevalence of heart failure are increasing globally, and management involves lifestyle changes and pharmacological treatments. Dietary recommendations for sodium and fluid restriction are expected to benefit HF patients, but there is currently a lack of clear evidence to support this.

KOREAN JOURNAL OF INTERNAL MEDICINE (2022)

Review Cardiac & Cardiovascular Systems

Hypertension and heart failure with preserved ejection fraction. A past, present, and future relationship

M. Camafort, O. Valdez-Tiburcio, F. Wyss

Summary: Heart failure with preserved ejection fraction (HFpEF) is a common syndrome associated with high cardiovascular and non-cardiovascular morbidity and mortality. Hypertension is one of its major risk factors and plays a role in its development and prognosis. The guidelines recommend renin-angiotensin system blockade as the mainstay of hypertension treatment in HFpEF patients. Other medications such as spironolactone and angiotensin receptor-neprilysin inhibitors are also recommended in certain cases. New treatments, such as sodium-glucose cotransporter-2 (SGLT2) inhibitors, and promising treatments like finerenone, are emerging. A phenotypic classification and further research on pending issues are needed.

HIPERTENSION Y RIESGO VASCULAR (2022)

Editorial Material Peripheral Vascular Disease

A Further Step to Classical Semiology: The Subtle Expression of Structural and Functional Cerebral Changes in Hypertension

Antonio Coca, Miguel Camafort

AMERICAN JOURNAL OF HYPERTENSION (2022)

Article Cardiac & Cardiovascular Systems

Angiotensin Receptor Blockers Evaluated by Office and Home Blood Pressure Measurements. TeleHBPM Study

Weimar Kunz Sebba Barroso, Andrea Araujo Brandao, Priscila Valverde de Oliveira Vitorino, Audes Diogenes de Magalhaes Feitosa, Eduardo Costa Duarte Barbosa, Roberto Dischinger Miranda, Josep Redon, Miguel Camafort-Babkowski, Antonio Coca, Marco Antonio Mota Gomes

Summary: This study described the use of angiotensin receptor blockers and their effectiveness in controlling arterial hypertension. The results showed that losartan was the most commonly used angiotensin receptor blocker, but it was the least effective in reducing and controlling blood pressure. Combinations of angiotensin receptor blockers with diuretics or calcium channel antagonists resulted in lower blood pressure values.

ARQUIVOS BRASILEIROS DE CARDIOLOGIA (2022)

Review Cardiac & Cardiovascular Systems

Risk Factors and Cardiovascular Disease in the Elderly

Pablo Diez-Villanueva, Cesar Jimenez-Mendez, Clara Bonanad, Sergio Garcia-Blas, Angel Perez-Rivera, Gonzalo Allo, Hector Garcia-Pardo, Francesc Formiga, Miguel Camafort, Manuel Martinez-Selles, Albert Ariza-Sole, Ana Ayesta

Summary: Age is associated with increased cardiovascular risk factors and disease, which leads to high morbidity and mortality in the elderly population. This comprehensive review examines the impact of important cardiovascular risk factors on cardiovascular disease in the elderly, highlighting the importance of diagnosis, treatment, and prevention. It also explores the relationship between cardiovascular disease and comorbidities and geriatric conditions, such as frailty, and addresses other aging-related issues like genetics, heart changes, and oxidative stress.

REVIEWS IN CARDIOVASCULAR MEDICINE (2022)

Article Geochemistry & Geophysics

Active Tectonics of the North Tunisian Continental Margin

Miquel Camafort, Cesar R. Ranero, Eulalia Gracia

Summary: The Nubia and Eurasian plates have a poorly defined boundary along the Northern Tunisian continental margin. The Tunisian margin is deformed by slow convergence, resulting in a diffuse deformation zone with less seismic activity compared to neighboring regions. This study analyzes the active tectonics in this submarine margin using high-resolution bathymetric maps and echosounder images, revealing a predominance of transpressive to compressive faulting. The North-eastern Domain of the study area has the highest number of active faults.

TECTONICS (2022)

Article Cardiac & Cardiovascular Systems

Comprehensive Therapeutic Approach to Hypertension. Recommendations for Central America and the Caribbean

F. Wyss, O. Valdez, M. Camafort, A. Coca

Summary: Latin American hypertension guidelines should be known and applied by most physicians in Central and South American countries, which poses a significant challenge for hypertension societies in the region.

HIPERTENSION Y RIESGO VASCULAR (2023)

Review Medicine, General & Internal

How low should blood pressure be in patients with chronic coronary and cerebrovascular diseases

A. J. Manolis, M. S. Kallistratos, M. Camafort, A. Coca

Summary: Over the past three decades, there has been an increasing focus on the fact that lowering blood pressure below a critical point may no longer be beneficial, but possibly harmful. Recent trials and meta-analyses have found that intensive blood pressure lowering can reduce cardiovascular events and mortality, but the data may not be applicable to the general hypertensive population. Different guidelines recommend different blood pressure thresholds for specific clinical situations, such as coronary artery disease and stroke, creating a challenge in determining the limits of intervention and identifying vulnerable patients.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2023)

Article Peripheral Vascular Disease

Feasibility and measurement stability of smartwatch-based cuffless blood pressure monitoring: A real-world prospective observational study

Minju Han, Young-Ro Lee, Taeyoung Park, Sang-Hyun Ihm, Wook Bum Pyun, Thilo Burkard, Myeong-Chan Cho, Miguel Camafort, Eugene Yang, George S. Stergiou, Hae Young Lee, Jong-Mo Seo, Korean Soc Hypertension

Summary: This study evaluated the feasibility and measurement stability of smartwatch-based cuffless blood pressure monitoring in real-world conditions. The results showed that smartwatch-based blood pressure monitoring is feasible for out-of-office monitoring in patients. Blood pressure levels showed considerable variability, mainly depending on the time and day of measurement.

HYPERTENSION RESEARCH (2023)

Review Medicine, General & Internal

Current Role of SLGT2 Inhibitors in the Management of the Whole Spectrum of Heart Failure: Focus on Dapagliflozin

Carlos Escobar, Domingo Pascual-Figal, Luis Manzano, Julio Nunez, Miguel Camafort

Summary: Based on recent evidence, SGLT2 inhibitors, specifically dapagliflozin, are recommended as first-line therapy for managing heart failure patients, irrespective of ejection fraction, to reduce the burden of heart failure. Studies have shown that dapagliflozin significantly reduces the risk of cardiovascular death, all-cause death, total heart failure hospitalizations, and MACE in the entire spectrum of heart failure, with sustained benefits over time. Full implementation of dapagliflozin in clinical practice leads to a substantial reduction in hospitalizations for heart failure and death in real-life populations.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Medical Laboratory Technology

Specific test panels for patients with heart failure: implementation and use in the Spanish National Health System

Luis Almenar Bonet, Ma Teresa Blasco Peiro, Begona Laiz Marro, Miguel Camafort Babkowski, Antonio Buno Soto, Andmaria Generosa Crespo-Leiro

Summary: This study investigated the use of specific test panels (STP) for heart failure (HF) in Spain and gathered expert opinions. The results showed that despite some limitations, experts generally believed that STPs have a positive impact on the diagnosis and monitoring of HF. However, efforts are still needed to achieve standardization and homogenization.

ADVANCES IN LABORATORY MEDICINE-AVANCES EN MEDICINA DE LABORATORIO (2022)

Meeting Abstract Peripheral Vascular Disease

INFLUENCE OF SYSTOLIC BLOOD PRESSURE CONTROL IN ELDERLY PATIENTS WITH CHRONIC HFPEF

Jiwei Chen Qin, Marcos Sanchez Sanchez, Esther Vinas Esmel, Miriam Costafreda Mas, Miguel Camafort Babkowski

JOURNAL OF HYPERTENSION (2022)

Meeting Abstract Peripheral Vascular Disease

INFLUENCE OF SYSTOLIC BLOOD PRESSURE CONTROL IN ELDERLY PATIENTS WITH CHRONIC HFPEF

Jiwei Chen Qin, Marcos Sanchez Sanchez, Esther Vinas Esmel, Miriam Costafreda Mas, Miguel Camafort Babkowski

JOURNAL OF HYPERTENSION (2022)

Meeting Abstract Peripheral Vascular Disease

AMBULATORY BLOOD PRESSURE MEASUREMENT AS A PREDICTOR OF HYPERTENSION MEDIATED TARGET ORGAN DAMAGE IN VERY ELDERLY POPULATION: THE MAPACHESS STUDY

Marcos Sanchez Sanchez, Jiwei Chen Qin, Esther Vinas-Esmel, Miriam Costafreda Mas, Manuel Torres, Rosa Martinez Ferre, Cristina Benitez, Cristina Sierra Benito, Antonio Coca Payeras, Miguel Camafort Babkowski

JOURNAL OF HYPERTENSION (2022)

No Data Available